Vanguard Capital Management’s Whitehawk Therapeutics WHWK Stock Holding History
Bought
Maintained
Sold
Other funds holding WHWK
YF
SL
Vanguard Capital Management's WHWK Position: Q3 2026 in Review
Vanguard Capital Management increased its Whitehawk Therapeutics (WHWK) stake by 5.6% in Q3 2026, buying an estimated $326K and bringing the position to 1,465,827 shares worth $5.51M. The position accounts for ﹤0.01% of the portfolio, ranked #3046.
Vanguard Capital Management first reported a position in WHWK in Q1 2026 and has held it in 3 quarters since. The position peaked at $6.36M in Q2 2026. 91 funds tracked by Wall St. Rank hold WHWK as of Q3 2026.
- Vanguard Capital Management held 1,465,827 shares of Whitehawk Therapeutics worth $5.51M as of Q3 2026.
- Vanguard Capital Management bought 77,266 Whitehawk Therapeutics shares in Q3 2026, an estimated $326K.
- Whitehawk Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3046 holding.
- Vanguard Capital Management first reported a position in Whitehawk Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Whitehawk Therapeutics position peaked at $6.36M in Q2 2026.
- 91 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.